Neurochemistry of the hippocampus in patients with obsessive-compulsive disorder

dc.contributor.authorAtmaca, Murad
dc.contributor.authorYildirim, Hanefi
dc.contributor.authorOzdemir, Huseyin
dc.contributor.authorKoc, Mustafa
dc.contributor.authorOzler, Sinan
dc.contributor.authorTezcan, Ertan
dc.date.accessioned2026-08-12T17:45:45Z
dc.date.issued2009
dc.departmentFırat Üniversitesi
dc.description.abstractAim: To date, despite possible neuroanatomical importance, no magnetic resonance spectroscopy (MRS) study on hippocampus has been performed in obsessive-compulsive disorder (OCD). The purpose of the present study was therefore to compare hippocampal chemicals in patients with OCD with those in healthy subjects with no psychopathology. Methods: Eighteen patients meeting DSM-IV criteria for OCD and 18 healthy controls were studied. The patients and controls underwent proton magnetic resonance spectroscopy ((1)H-MRS), and measures of N-acetyl-l-aspartate (NAA), choline (CHO), and creatine (CRE) in hippocampal regions were obtained. Results: Both NAA/CRE and NAA/CHO ratios in the hippocampus in patients with OCD were reduced relative to healthy controls. The ANOVA showed a near-significant effect of diagnosis for NAA/CRE and a significant effect for NAA/CHO, but the ANOVA did not show any significant effect even at a trend level for CHO/CRE. No main effect of hemisphere was found for any metabolite ratio. Conclusions: The presence of neuronal degeneration is suggested in OCD. Future longitudinal neuroimaging and neuropsychological studies with larger patient samples are warranted in order to confirm these preliminary findings to better characterize the relevance of neurochemical abnormalities in hippocampus in the pathophysiology of OCD.
dc.identifier.doi10.1111/j.1440-1819.2009.01993.x
dc.identifier.endpage490
dc.identifier.issn1323-1316
dc.identifier.issue4
dc.identifier.pmid19531109
dc.identifier.scopus2-s2.0-68149176461
dc.identifier.scopusqualityQ1
dc.identifier.startpage486
dc.identifier.urihttps://doi.org/10.1111/j.1440-1819.2009.01993.x
dc.identifier.urihttps://hdl.handle.net/11508/60817
dc.identifier.volume63
dc.identifier.wosWOS:000268101000008
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley-Blackwell Publishing, Inc
dc.relation.ispartofPsychiatry and Clinical Neurosciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectcholine
dc.subjectmagnetic resonance spectroscopy
dc.subjectN-acetylaspartate
dc.subjectobsessive-compulsive disorder
dc.subjectspectroscopy
dc.titleNeurochemistry of the hippocampus in patients with obsessive-compulsive disorder
dc.typeArticle

Dosyalar